Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries by Helena Hůlková et al.
ORIGINAL ARTICLE
Abnormal nonstoring capillary endothelium: a novel feature
of Gaucher disease. Ultrastructural study of dermal capillaries
Helena Hůlková & Helena Poupětová & Klaus Harzer &
Pramod Mistry & Johannes M. F. G. Aerts &
Milan Elleder
Received: 28 July 2009 /Revised: 30 October 2009 /Accepted: 10 November 2009 /Published online: 5 January 2010
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Ultrastructural study of skin biopsies in two
cases of Gaucher disease (GD) patients (types II and III)
revealed hitherto unknown alteration of the blood capillary
endothelial cells (ECs) featured by hypertrophy and
numerous subplasmalemmal microvesicles underneath both
the apical and basal membranes. There was also prominent
apical membrane folding with formation of filiform and
large cytoplasmic projections, with occasional transcapil-
lary cytoplasmic bridges. Similar, though less frequently
expressed, changes were manifested at the basal membrane
by numerous cytoplasmic projections into the subendothe-
lial space. Regressive changes with EC breakdown were
rare. Lysosomal storage was always absent. Besides EC
hypertrophy, there was also increased EC density in the
capillary lumen, leading to pronounced changes in capillary
architecture with loose or incomplete EC anchoring. There
were also signs of EC sprouting. Some pericytes displayed
an increase in size and number of cytoplasmic processes,
which often extended into distant pericapillary regions. The
spectrum of changes suggests that a significant positive
growth effect on EC occurs in GD. The putative mecha-
nisms triggered by GBA1 deficiency leading to EC
involvement are discussed. The authors are well aware of
the fact the results, based on a nontraditional type of bioptic
samples, are preliminary, but they are worth following, as
further ultrastructural and functional studies of blood
endothelium in GD may open a novel field in molecular cell
pathophysiology of the disorder: endothelial dysfunction.
Introduction
Gaucher disease (GD) was first described in 1882 by a young
medical student. Molecular delineation commenced in 1934
with identification of the nature of stored lipid, followed
31 years later by recognition of metabolic defect in the form of
inherited deficiency of glucocerebrosidase (GCase), and
16 year later by characterization of the GBA1 gene and
description of the first disease mutations. Many of these
milestones are elegantly described in a monograph edited at
the occasion of centennial anniversary of the description of
the disorder (Desnick et al. 1982). Knowledge of cellular
pathology of this most frequent lysosomal enzymopathy is
generally viewed as storage restricted to macrophages trans-
formed into cytologically unique Gaucher cells (GC) charac-
terized by active secretion of numerous molecules, some of
which are in use as biomarkers in clinical practice (Aerts and
Hollak 1997; Boven et al. 2004; Cox 2005; Deegan et al.
2005). Lysosomal storage in other cell types has never been
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reported. Therefore, the pathological focus has been on the
pattern of GC infiltration in different organs. Interestingly,
neurodegeneration, a feature of GD type II, is not associated
with lysosomal storage and is believed to involve direct toxic
effects of glucosylsphingosine on neuronal cells. The current
understanding of the pathology of GC is described compre-
hensively in excellent monographs (Beutler and Grabowski
2001; Lee 1982; Lee 2007). However, there are significant
gaps in our understanding of the pathophysiologic basis of
GD and cell types involved. Notably, there is a discrepancy
between generalized enzymopathy that occurs in GD and
restriction of lipid storage structures to one cell type, which
led one of us to propose a hypothesis that might bridge the
persisting gap between the firmly established molecular
definition and the loosely defined cell pathology (Elleder
2006). In this report, we present for the first time prominent
alteration of the capillary endothelial cells (ECs) disclosed by
routine ultrastructural examination of skin biopsies of patients
with type II and type III GD. To the best of our knowledge,
we are not aware of any study of ECs in GD, despite the
voluminous literature (see above) and recent report (Chen and
Wang 2008). Reports on skin pathology are limited to clinical
observations in GD I (Goldblatt and Beighton 1984). Reports
on all types of early-onset GD focused on epidermal
abnormalities (Holleran et al. 1994a, b, 2006; Reissner et al.
1998; Sharma et al. 2000; Sidransky et al. 1992) or general
histology (Eblan et al. 2005; Mignot et al. 2003; Sherer et al.
1993; Spear et al. 2007; Stone et al. 1999; Van Gysel et al.
2002). Also, reports on mouse models of GD did not mention
EC status. Our findings of dermal capillaries point to a novel
aspect of pathology of GD: remarkably intensive alterations
of blood capillary endothelium suggesting EC overstimula-
tion. This prompts consideration of the presence of a novel
aspect of the pathophysiology of GD, i.e., that of endothelial
dysfunction and its implications in several mechanisms of




Case 1 A male infant presented with severe hepatospleno-
megaly, psychomotor retardation associated hypertonia, and
tendency to opisthotonus. Interestingly, the child exhibited
discrete reddish cutaneous maculae. Skin biopsy was taken
at the age of 10 months. He died at the age of 13 months.
Autopsy was not performed. Glucocerebrosidase (GCase)
activity in white blood cells (WBC) was 1.7 nmol/mg
protein/h [controls 6.5–16.9, mean ± standard deviation
(SD) 9.34±1.75, n=113); in cultured skin fibroblasts
6 nmol/mg protein/h (controls 154–536, mean ± SD 322±
119, n=15). Sequencing the GBA1 gene revealed the
patient to be compound heterozygote for L444P and
S107L mutations (Hodanova et al. 1999). Chitotriosidase
activity in plasma was not determined. The patient was
classified as having type II GD.
Case 2 A boy aged 2 years presented with prominent
hepatosplenomegaly, pancytopenia, and minimal neurological
involvement manifesting as mild oculomotor symptoms with
slowed, hypometric, horizontal saccades and suspected con-
vergent strabismus. Skin was grossly normal without any
efflorescences. Skin biopsy was taken at the age of 21 months.
GCase activity in cultured skin fibroblasts was 13.6 nmol/mg
protein/h (4.2% of control mean value). GBA1 gene analysis
revealed the patient to be homozygous for L444P mutation.
Chitotriosidase activity in plasma was 16,065 nmol/ml per
hour (normal value <80). The patient’s presentation and
phenotype was consistent with type III GD.
Methods
Skin biopsies were taken for diagnostic purposes after
informed consent was given the by patients’ mothers in
accordance with the Declaration of Helsinki. Skin
biopsies, taken from the medial side of the upper arm
of both patients were fixed in 4% paraformaldehyde
(case 1) or 2% glutaraldehyde (case 2), embedded using
standard processing procedures into an Epon-Araldite
mixture, double stained, and examined using a Tesla 500
electron microscope and a Jeol 1200 EX. Endothelial
ultrastructure was compared with series of skin biopsies
of patients without diagnosis of lysosomal storage
disorders.
GCase activity was determined in leukocytes and fibro-
blasts as described by Wenger and Williams (1991) using the
artificial fluorogenic substrate 4-methylumbelliferyl-β-D-
glucopyranoside (Sigma M 3633). Protein concentration
was determined by the method of Hartree (Hartree 1972).
Enzyme analysis was done in the same laboratory.
Results
Ultrastructure of dermal capillaries
Dermal capillaries were not generally increased in number.
However, they were frequently found to be in clusters. The
general capillary architecture had frequent and significant
alterations, with increased size and irregular contours. In
longitudinally oriented sections, the tortuosity was very
apparent (Fig. 1a, b). The number of ECs was increased
(4–6/capillary) compared with controls (2–3 ECs/capillary).
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EC size was clearly increased and the cytology altered. EC
enlargement was substantial, resulting in a marked reduc-
tion or obstruction of the capillary lumen (Fig. 1d, 2c). In
many capillaries, EC apical pole protruded frequently into
existing lumina through polyp-like projections (Fig. 2c, d).
Occasionally, there were cytoplasmic bridges extending
across the capillary lumen (Fig. 2b). In some capillaries
with higher EC densities, ECs displayed loose or incom-
plete intercellular connections, resulting in decreased EC
anchoring (Fig. 1a, b, 2a).
The expanded EC cytoplasm contained variable numbers
of Weibel-Palade granules of various sizes, as well as
clusters of typical mitochondria with relatively dense inner-
membrane cristae. Frequently, there were thick bands of
intermediate filaments (8.4 nm in diameter). Lysosomal
storage was never observed. Nonspecific, discrete lipofuscin
granules were exceptional. Rarely, there were typical small
multivesicular bodies. The Golgi endoplasmic reticulum
complex was generally present, and the external nuclear
lamina was easily discernible. Numerous cytoplasmic ribo-
somes (≈25 nm in diameter) were present in all cases.
There were numerous subplasmalemmal vesicles resem-
bling caveolae (≈83 nm in diameter) beneath both the
apical and basolateral poles and accompanied by larger
microvesicles (up to 170 nm in diameter) deeper in the
cytoplasm. The nuclei were enlarged with irregular
contours, frequently cleaved or multilobed, with slender
junctional segments and rich in euchromatin. Condensed
chromatin was present only at the nuclear periphery.
Mitosis was not seen. The apical poles of the ECs
frequently displayed an enormous degree of irregularity,
with many folds of various sizes, thickness, and density or
with many discrete filiform-type projections protruding
noticeably into the capillary lumen. They contained
mainly ribosomes, infrequently admixed with occasional
microvesicles, and exceptionally with Weibel-Palade
granules (Fig. 1d, 2d). In some ECs, the apical cytoplasm
protruded deeply into the capillary lumen (Fig. 1c).
Fig. 1 a Dermal capillary (case 2) showing numerous enlarged
endothelial cells (ECs) with prominent folding of both the apical and
basal pole membranes. b Dermal capillary (case 2) showing enlarged,
irregular ECs with uneven apical pole membranes. One of them can be
seen to be loosely anchored. Li lipopigment deposits. c Dermal
capillary (case 1) showing enlarged ECs with prominent folding at the
basal pole and limited by a multilayered basement membrane. ECs
display loose intercellular connections. The apical part of the EC at the
center protrudes prominently into the capillary lumen. d Dermal
capillary (case 2) with an obliterated lumen caused by enlarged ECs.
Note the prominent folding of the apical membranes and fusion
between opposite ECs. Note also the loose intercellular connections
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The basal pole was serrated and frequently folded with
cytoplasmic, foot-like extensions, projecting into the peri-
capillary space, forming a fragmentary or complete second
endothelial layer (Fig. 2a). Each of the extensions displayed
a basement membrane on its external surface. Basement
membranes were generally thin and frequently multiple and
admixed with the aforementioned basal EC extensions.
Occasionally, the EC basement membranes were barely
detectable, especially underneath prominently enlarged ECs
(Fig. 2c). Degenerative changes were exceptional but were
occasionally observed in individual ECs (Fig. 3a).
There were recurrent findings suggestive of angiogenesis,
i.e., sprouting of tip-like EC or tube-like structures with
primitive lumina lined by less differentiated ECs. In some
cases, the cytoplasm was free of nuclei (Fig. 3c). Pericytes
were observed to participate in the process. Process
compatible with intussusceptive type angiogenesis was also
observed. ECs protruding into the capillary lumina had
nuclei situated within the luminal part (Fig. 3d). Capillaries
with near-normal ECs were infrequent. Their cytoplasm was
narrow and less differentiated.
Some pericytes were significantly enlarged. Frequently,
the space between the pericyte inner aspect and EC outer
aspect was wider, without any sign of focal gap-junction
connections, suggesting abnormal fluid accumulation (per-
haps caused by leaky capillaries). There were often contacts
between slender EC projections and pericyte cytoplasm
(never direct fusion). Pericyte cytoplasm was rich in
caveolae, which were distributed along the cell membrane.
Some pericytes were completely detached and situated a
considerable distance from the capillary, without any sign
of cytoplasmic connections (as seen in plain section).
Despite the detachment, they were completely surrounded
by a pericellular membrane and shared cytoplasmic features
Fig. 2 a Dermal capillary (case 2) showing discontinuous endothelial
cells (ECs) displaying loose anchoring and formation of a second
endothelial layer. b Dermal capillary (case 1) with an enlarged single
EC. A prominently activated apical pole forms a transluminal bridge
(arrows). Note the large pericyte on the left. c Dermal capillary (case
2) with the lumen almost completely obliterated by the enlarged,
folded EC cytoplasm. Note the cytoplasmic transformation into a
dense mesh and the numerous Weibel-Pallade granules. The thin
basement membrane is almost invisible on the left side. d Dermal
capillary (case 2) showing details of EC apical membrane folding
together with numerous ribosomes and occasional microvesicles
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with classically positioned pericytes (Fig. 3b, Fig. 4), being
thus easily distinguishable from both individual dermal cell
fibroblasts and perivascular macrophages. The latter were
very rare and also never expressed any signs of typical
glucocerebroside storage structures, only nonspecific residual
bodies. No inflammatory changes were present. Capillary
endothelium of arterioles and venules was present irregularly
in the samples. Also, dermal lymphatic capillary endothelia
could not be followed systematically. However, in many
instances, both their nuclei and the perinuclear cytoplasm
were enlarged, with many apical microvesicles.
Other dermal structures
Fibroblasts, mast cells, nerves, and smooth muscle cells
(arrectores) were without recognizable structural alterations.
Generally, there were numerous altered mitochondria in the
excretory tubules of sweat glands. Similar structures are
seen in skin biopsies from a variety of conditions and most
probably represent a normal stage of the mitochondrial life
cycle (Carpenter 1988 and extensive personal experience).
The secretory parts of the eccrine glands were present only
in case 1 and were notable for their high degree of
enlargement. In this sense, they differed significantly from
skin eccrine glands at this age level (ME, unpublished
observation).
Comparative group
In the comparative group of 300 skin biopsies of young
children (≈1–4 years of age), EC changes were limited to
enlargement of EC nuclei. Less frequently, there was
enlargement of the cytoplasm with numerous Weibel-
Palade granules, abundant bundles of intermediate fila-
ments, increased numbers of mitochondria, and occasional
multivesicular bodies. Cell membranes at both the apical
and basolateral poles were even, without any substantial
irregularities, suggestive of activation. Multiple basement
Fig. 3 a Dermal capillary (case 1) showing a level of degeneration
approaching cytoplasmic lysis (asterisks). b Dermal capillary (case 2)
showing endothelial-cell (EC) hypertrophy and numerous surrounding
pericytes. Note that one of the pericytes (P) is some distance from the
capillary and completely detached but still expresses a pericellular
membrane and subplasmalemmal microvesicles around its entire
perimeter. c Dermis (case 1) showing structures compatible with EC
sprouting. There is a single EC (EC) with three cytoplasmic
extensions, one of them definitely luminized (Lu). d Branched dermal
capillary (case 1). Note the large lumen at the right lined with very
thin EC cytoplasm. On the left are three enlarged ECs, which are
prominently protruding into the obliterated lumen. The architectural
pattern is compatible with intussusceptive-type angiogenesis
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membranes and endothelial foot processes in the subendo-
thelial space were scarcely seen. Pericytes, when present,
were typically positioned, without any signs of systemic
enlargement. Quite exceptionally, in three cases in which
lysosomal storage, including GD, had been excluded, there
were changes in some EC comparable with those seen in
the case studies in this report.
Discussion
The spectrum of changes in the blood capillary endothelium
described herein in GD points to classical hypertrophy
represented by an enlarged nuclear compartment rich in
euchromatin, increased cytoplasmic volume, and increased
numbers of organelles, with the number of free ribosomes
and amount of rough endoplasmic reticulum pointing to
upregulation of proteosynthesis. These changes were
accompanied by a prominent modulation of cell mem-
branes, which suggests a considerable increase in their
dynamics. It was expressed mainly in the luminal apical
membranes, frequently to a remarkable degree, but also at
the basal EC pole. The latter often displayed a highly
serrated appearance and an increased size of the endothelial
basal foot projections, which frequently created a second
endothelial layer (Pavelka and Roth 2005). EC hypertrophy
was accompanied by a process strongly resembling both
types of angiogenesis (Burri and Djonov 2002; Djonov et
al. 2003; Risau 1997): (a) intussusceptive (with various
degrees of transcapillary pillar formation), and (b) sprouting
type (with luminal expansions of various types). Regressive
changes were rare and restricted to individual ECs.
However, the presence of multiple basement membranes,
resembling the situation in diabetes mellitus (Vracko and
Fig. 4 Comparative group of skin biopsies showing variability of capillary endothelial cell (EC) appearance. a Flat EC, a frequent finding. b, c
Larger EC with rudimentary folding of the apical membrane. d Enlarged EC with smooth membranes at both apical and basal poles
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Benditt 1974), suggests increased turnover either of all ECs
or turnover confined to basal pole processes. It should be
stressed that there were no signs of glucocerebroside
storage structures.
Taken together, there were signs of prominent EC
hypertrophy, including a certain degree of angiogenic hyper-
plasia and focal regressive changes suggesting occurrence of a
chronic stimulatory effect. EC changes resembled EC
activation described in several experimental systems (Agha-
Majzoub et al. 2005; Dye et al. 2004; Fujimoto et al. 2004;
Walski and Frontczak-Baniewicz 2003) or changes described
in various spontaneous conditions such as adaptive capillary
growth in overloaded rat skeletal muscles, (Zhou et al. 1998)
inflammation (Polosukhin 1997), acute rejection of human
renal allograft (Liptak et al. 2005), and other spontaneous
conditions and experimentally induced states (Martin et al.
1980; Norrby 1997; Polverini 1995), which are generally
classified as EC activation.
As these known causes of EC activation were absent in
the two patients, we suggest two possible explanations of
the phenomenon, both capable of exerting chronic EC
activation effect. First, it is challenging to assess the direct
role of enzymopathy. If enzymopathy plays a role in the
development of the EC abnormalities described herein, the
mechanisms a priori have to involve those other than
accumulation of lysosomal glucocerebroside structures, as
these are absent in this cell type. It should be kept in mind
that the direct role of enzymopathy in type II GD results in
neurodegeneration by pathways that appear not to involve
lysosomal accumulation of glucocerebroside structures. It is
of interest in this connection to point out that low-density
lipoprotein (LDL) in patients with GD contains markedly
elevated glucosylceramide and gangliosides, suggesting
that many cell types, including ECs, are chronically
supplied with increased amounts of glycosphingolipids
destined for turnover (Ghauharali-van der Vlugt et al.
2008; Groener et al. 2008). Recently, one of us (Elleder
2006) proposed a more generalized involvement of diverse
cells types in GD other than macrophages. In this paradigm,
cell types other than macrophages are envisaged to have
efficient transport mechanisms for accumulating glucocer-
ebroside out of the lysosome were it becomes available as
substrate for hydrolysis by neutral GCase (GBA2) (Boot
et al. 2007; van Weely et al. 1993; Yildiz et al. 2006). Such
a pathway may play a role in EC activation described
herein via generation of ceramide and aberrant cell
signaling thereof (Elleder 2006), similarly to what was
described recently in studies of the mechanism of acute
hypoxic pulmonary vasoconstriction (Cogolludo et al.
2009). Glucocerebroside itself may also have signaling
activity, and its lysoproduct, glucosylsphingosine, also
increased in GD, might contribute to EC cytotoxicity,
activating cytokine imbalance. Recently, an ex vivo study
in experimentally induced GC showed increase in GlcCer
in microdomains (Hein et al. 2008), suggesting the
possibility of their functional alteration.
Secondly, mechanisms underlying EC activation in GD
could involve the role of cytokines and growth factors
produced and secreted by activated macrophages as they
transform into fully mature GCs (Cox 2005; Deegan et al.
2005; Hollak et al. 1997a; Michelakakis et al. 1996). This
should be explored in the future by measureing cytokines
and growth factors [i.e., vascular endothelial growth factor
(VEGF)] in sera of GD patients, especially those who
exhibit prominent vascular phenotypes such as pulmonary
hypertension, hepatopulmonary syndrome, and splenic
vascular lesions. In contrast to finding noted herein, in
sarcoidosis, another disease involving macrophage activa-
tion, there are predominantly regressive changes of ECs
(Planes et al. 1994; Tsukada et al. 1995) combined with
inflammation and necrosis (Takemura et al. 1997). A
picture of reactive angioendotheliomatosis with prominent
endothelial capillary proliferation rarely seen in sarcoidosis
(Shyong et al. 2002) was absent in our patients.
Taken together, the findings described herein strongly
implicated EC activation and dysfunction in the pathophy-
siology of GD. The mechanisms responsible for EC
transformation in GD can be most efficiently elucidated
by exploring cultured ECs from GD patients and concurrent
studies of newly developed authentic mouse models of the
disease. Moreover, there is now the prospect of developing
double-knock-out mouse models of GBA1 and GBA2
genes, which is especially pertinent to the concepts outlined
herein. Such studies may challenge the macrophage-centric
view of GD and help explain several features of the disease
that currently defy explanation (Elleder 2006) i. e.,
tendency to pulmonary hypertension (Elstein et al. 2005)
or permanent hypercoagulability and its consequences in
GD (Adar et al. 2008; Elstein et al. 2000; Hollak et al.
1997b), as well as why patients with GD suffer from
avascular osteonecrosis, when in fact there is evidence of
increased vascularity (P. Mistry, unpublished observation).
It is worth mentioning that recently advanced proteomics
technology available to sensitively quantify plasma proteins
revealed in GD patients marked abnormalities in coagula-
tion and complement pathways that were partly corrected
by enzyme replacement therapy (Vissers et al. 2007).
Numerous extensions at the apical pole membrane
suggest greatly increased tendency for endothelial micro-
particle formation (Lynch and Ludlam 2007). In fact, their
increased production of EC-derived microparticles has been
demonstrated (JM Aerts, unpublished observations), espe-
cially in splenectomized GD patients. In patients with
splenomegaly, increased clearance of microparticles by the
enlarged spleen most likely explains the relatively low
levels of circulating EC-derived microparticles.
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In the series of Fabry hemizygotes, the blood capillaries
manifested typical storage processes in ECs as well as in
pericytes. The ECs engorged with lysosomal storage
material in this setting displayed cytoplasmic enlargement
proportional to the degree of lysosomal storage. In Fabry
disease, alterations of apical and basal cell membranes are
not found in contrast to those present in our GD patients.
The apical membrane projections were present but only
exceptionally prominent. The subendothelial basement
membranes were frequently multiplied. In angiokeratoma
of Fabry disease, in contrast, ECs were thin, despite the
presence of storage lysosomes (Elleder 2003). It would be
instructive to compare endothelial function and morphology
in GD with Fabry disease. In the mouse model of Fabry
disease, signs of EC dysfunction have been described (Eitzman
et al. 2003; Park et al. 2008). Moreover, in Fabry disease
patients, enzyme replacement therapy led to a decrease in
circulating endothelial microparticles (Gelderman et al.
2007). A recent survey of a cohort of 36 Fabry disease
patients, however, revealed only minimal abnormalities in
endothelial microparticles, and of markers for platelet and
endothelial activation, coagulation activation and fibrinolysis.
The earlier reported abnormalities in severely affected Fabry
disease patients seem to be better explained by renal
insufficiency than Fabry disease itself (Vedder et al. 2009 ).
In GD patients, EC changes dominated over those seen
in pericytes, which were changed to a lesser degree.
However, there were definite signs of their activation, and
it is important to keep in mind that their activation may be
connected with calcifications (Armulik et al. 2005),
repeatedly seen, e.g., in GD II (Mignot et al. 2003; Sherer
et al. 1993; Spear et al. 2007).
Our results are descriptive but make a compelling case for
further study of ECs in GD. The unique morphological pattern
in individual capillaries taken together with remarkable
tendency to EC loose anchoring as well as their protrusion
into the lumen argues strongly for a pathophysiologic role of
resident ECs and their possible increased exchange within the
pool of circulating EC precursors (Hristov et al. 2003; Xu
2007).
Conclusion and perspectives
We are well aware of the limitations of our study, which is
restricted to the thus far nontraditional type of bioptic
sample. However, interest should concentrate on skin
biopsies in further cases and types of GD, first to
nonneuronopathic GD type I (before and during enzyme
replacement theraphy), and to the capillary network
generally, as this may open and define a novel field in
molecular cell pathophysiology of the disorder: endothelial
dysfunction.
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